Table 1. Case studies considered.
Case Study | Number of populations | Population size | Complexity |
1) Tumour/Effector | 2 | 5 to 600 | Low |
2) Tumour/Efector/IL-2 | 3 | Medium | |
3) Tumour/Effector/IL-2/TGF- | 4 | High |
Case Study | Number of populations | Population size | Complexity |
1) Tumour/Effector | 2 | 5 to 600 | Low |
2) Tumour/Efector/IL-2 | 3 | Medium | |
3) Tumour/Effector/IL-2/TGF- | 4 | High |